For Quick Alerts
For Daily Alerts

Glenmark shares drop as MSD takes it to Court


Shares in domestic pharma company Glenmark dropped after report's that Merck's Indian unit, MSD, has filed a case against the company in the Delhi High Court for infringement of intellectual property rights.

The shares of the company were last trading at Rs 483, after touching a low of Rs 479 in trade today.

Most of the domestic pharma stocks continued to rally in trade following a Supreme Court verdict against MNC pharma company Novartis.


Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity) with five molecules in various stages of clinical development.

The company has a significant presence in branded generics markets across emerging economies including India. Its subsidiary, Glenmark Generics Limited has a fast growing and robust US generics business.

The subsidiary also markets APIs to regulated and semi-regulated countries. Glenmark employs over 10,000 people in over 80 countries. It has thirteen manufacturing facilities in four countries and has five R&D centres.

Read more about: glenmark
Story first published: Wednesday, April 3, 2013, 10:22 [IST]
Company Search
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more